CEACAM5 and neoplasm: When in terms of tumor downstage, patients who achieved tumor downstage were characterized with lower post-treatment CEA level (3.75 vs 4.51, P=0.043) and lower CEA ratio (0.28 vs 0.38, P=0.025), when compared with those did not.